What resveratrol is

The INCI name is simply RESVERATROL, CAS 501-36-0, formula C14H12O3, molecular weight about 228 Da, chemically 3,4',5-trihydroxystilbene with the trans configuration predominant. It is a phytoalexin — a defence substance plants secrete under stress or pathogen attack, the same origin story as many other plant polyphenols. The main commercial source is Japanese knotweed (Polygonum cuspidatum) root extract, usually standardised to ≥98% by HPLC; it can also be produced at scale chemically, commonly via a Wittig reaction joining the two benzene rings. Purchasing documents must state the source basis — natural extract or chemical synthesis: the two differ in label communication, customer preference and impurity profile in some markets, so the supplier COA and a source statement should be provided together.

Its physico-chemical profile is the key to understanding it, because its strengths and weaknesses share a single origin: a white to off-white fine powder, melting point about 253–255 °C, extremely low water solubility (about 3 mg / 100 mL), yet freely soluble in ethanol, propylene glycol, DMSO and some oils. The three phenolic hydroxyl groups on the molecule are both the source of its antioxidant capacity — a phenolic OH can donate a hydrogen atom to neutralise a radical — and the reason it oxidises readily, discolours and interacts with metal ions. The trans configuration is the form generally regarded as more stable and more usually assayed, but UV exposure drives isomerisation towards the cis form, which is the chemical basis for the hard rule that light must be excluded.

That gives resveratrol a clear character in project terms: it is a system ingredient, not a drop-it-in ingredient. Take the same 0.5% resveratrol serum in two versions — one in an opaque airless bottle, added at low temperature, with a partner antioxidant system and a colour release standard; the other in a clear dropper bottle, hot-charged straight into the water phase with no partner system — and after three months they may be two entirely different products, the latter very likely yellowed or browned with a marked drop in assay retention. In other words, in a resveratrol formula the solvent system, the packaging and the antioxidant partner outweigh the dose itself.

Ingredient fact box

How it works, plainly

The route can be split into three layers, from molecule to appearance: absorbing the hit at molecular level, reducing the cascade that oxidative pressure sets off, and reading as a little less fatigued. State this first: this section covers mechanistic hypotheses and literature at the cosmetic application level — it is not a medical explanation and carries no efficacy promise.

• Layer one: direct scavenging of reactive oxygen species (ROS). This is the core and the easiest to explain. Its three phenolic hydroxyl groups can donate hydrogen atoms directly, neutralising radicals and thereby interrupting the chain oxidation reaction. In cosmetic language this is expressed as "helps defend against oxidative pressure from the external environment" — note the boundary of that phrasing: say "helps defend" or "helps reduce the visible impact", never "repairs damage".
• Layer two: interaction with steps such as tyrosinase. Published work also reports effects in the direction of tyrosinase activity. Handle this one with real restraint: in China, whitening and spot-fading are special cosmetic function categories that a non-registered product may not claim on its own, and several markets treat the English word "whitening" cautiously too. This belongs as internal technical background only; consumer communication should return to the antioxidant thread.
• Layer three: what shows up visually. The upper layers appear as an eye area that reads less dull, less fatigued and more even in tone. Be honest: this is appearance language, not "reversing photo-ageing" and certainly not treatment of any skin condition. You may write "helps improve the look of fatigue around the eyes" or "helps defend against oxidative pressure from the environment"; you must not write "repairs oxidative damage", "reverses photo-ageing", "anti-tumour" or "protects cardiovascular health" — those are pharmacological and entirely out of bounds.
• An honest note on evidence strength. The published literature on resveratrol is large, but a substantial share concerns oral supplementation, metabolism and pharmacology, with concentrations, dosage forms and durations wholly unlike topical cosmetic use. Verify for yourself on PubMed with "resveratrol topical skin" and "resveratrol photoprotection". Lifting oral-study conclusions into cosmetic copy is the most common way this ingredient gets you into trouble, and no single study may be written up as proof of efficacy.
• How it divides work with other antioxidants. Resveratrol is not well suited to being sold as the single antioxidant; its proper place is the "direct scavenging and phenolic hydrogen donation" link inside an antioxidant network. Complementary partners include ergothioneine, which takes a different cell-protection route (see our ergothioneine eye care guide at ingredient.html?s=ergothioneine), vitamin E, which blocks oxidation chains in the oil phase, and ferulic acid, described in the literature as helping stabilise other antioxidants. An antioxidant network is about division of labour, not about piling on more actives.

A blunt note for sourcing: if the brief reads "antioxidant / defend against environmental stress", resveratrol is a mature story, highly recognisable and negotiable on cost. If the expectation is visible line or tone change within weeks, it will disappoint — its only honest story is gradual, cumulative protection and a less fatigued look over time. More importantly: because the oral-supplement literature on resveratrol is so large, supplier material often mixes in oral dosages and anti-tumour or cardiovascular conclusions, and none of that should be copied onto your product page.

Which formats fit resveratrol best?

Use level and formulation notes (verify by bench trial)

Common reference level: resveratrol commonly sits at about 0.1%–1.0% in skin-care products, with most formulas in the more conservative part of that range. Periorbital skin is thinner and less tolerant, and resveratrol itself carries irritation classifications in raw-material SDS documents (commonly for eyes and skin), so dosing usually starts at the lower end and is raised only against stability, colour shift and irritation data. One point deserves emphasis: oral dosages in the literature and topical use levels are two entirely different systems and must never be cross-quoted. The actual level is set on the bench by format, solvent system, target-market rules and stability data, converted against the assay on the supplier COA (commonly ≥98% by HPLC).

• Dissolution is constraint #1. At about 3 mg / 100 mL in water, resveratrol will almost certainly precipitate if charged directly into the water phase. The correct route is to pre-dissolve in ethanol, propylene glycol or a carrier oil to form a clear concentrate before incorporation; the choice of solvent must also clear regulation, since ethanol use is restricted in some markets and categories — confirm this early.
• Light stability is constraint #2. UV exposure drives the trans form towards cis and lowers assay retention. Control light during both manufacture and filling, prefer opaque bottles, airless pumps or aluminium tubes for the finished pack, and run both assay and colour observation under light exposure (including shelf simulation) on retained samples.
• Oxidative discolouration is constraint #3. Phenolic hydroxyls oxidise readily, and finished product drifting yellow or brown over time is the most common source of customer complaints. The usual measures are partner antioxidants such as vitamin E and ferulic acid, a suitable chelator (EDTA types) to control metal-ion catalysis, and a defined upper limit for colour shift in the release specification.
• Addition temperature and pH. Add the pre-dissolved resveratrol concentrate below 40 °C and avoid prolonged heat; keep pH at 4.0–7.0, since dissolved resveratrol becomes less stable as pH rises and alkaline systems should be avoided.
• Precipitation and recrystallisation. Run cold-storage (0–5 °C) and freeze–thaw observation at release, looking specifically for crystal formation or cloudiness; dilution behaviour must also be assessed in the complete formula, not inferred from raw-powder solubility data.
• Packaging compatibility. Beyond light exclusion, assess interaction between the bulk and the pack — especially tubes, metal pump components and gaskets, since metal ions are a common catalyst for oxidative discolouration.
• Stability protocol. 40 °C for 3 months, freeze–thaw and light-exposure conditions, with resveratrol retention (HPLC), colour (colorimeter or standard comparison), pH drift and precipitation observation as release criteria.
• Label and claim review. Before launch a regulatory adviser must confirm the usable boundary of "antioxidant / defends against environmental stress / anti-ageing" copy for each market, and explicitly exclude any pharmacological direction.

The figures above are common reference levels for eye care formulas; the actual use level is set by the formulation engineer based on dosage form, compatibility and target-market rules. Permitted use conditions, limits and labelling requirements differ by market — complete a compliance review for each destination before shipment. All descriptions here are general cosmetic applications and appearance or skin-feel statements, not medical advice or efficacy guarantees.

Compliance and market notes (verify per target market)

• China: first verify the listing status and historical maximum use level of Resveratrol (resveratrol) in the Inventory of Existing Cosmetic Ingredients in China (2021 edition) (per the latest NMPA announcement). Also note: if the material is filed as "虎杖 (POLYGONUM CUSPIDATUM) 根提取物", that INCI entry is not the same as "Resveratrol" — the two differ in label wording and quality-control basis and must not be used interchangeably. On claims, whitening and spot-fading are special cosmetic categories that a non-registered product may not claim on its own; for the antioxidant direction use wording such as "帮助抵御外界环境带来的氧化压力".
• EU (EC) No 1223/2009: declare the ingredient accurately in the CPNP notification, PIF and CPSR and complete the safety assessment; claims must meet the (EU) No 655/2013 common criteria. One caution is specific here: health claims attached to resveratrol in the oral-supplement context are governed by dedicated EU rules, and cosmetic copy must never carry them over. In EU COSING, resveratrol's function categories sit under antioxidant and skin-protecting.
• US MoCRA (2022): facility registration, product listing, safety substantiation, adverse-event reporting and record-keeping apply, with labelling under the FD&C Act and relevant 21 CFR provisions. Cosmetic ingredients and finished products generally do not undergo pre-market approval — never write "FDA approved". Also watch for any copy implying disease prevention or treatment, which risks being read as a drug claim.
• Claim red lines (all markets): never use pharmacological, medical or special-function wording such as "repairs oxidative damage", "reverses photo-ageing", "anti-tumour", "protects cardiovascular health", "anti-inflammatory", "slows ageing (medical sense)", "whitening" or "spot-fading". On the Chinese site use appearance and skin-feel wording such as "帮助抵御外界环境带来的氧化压力", "帮助改善眼周疲态外观" and "提升光泽感".
• Recommended action: at kick-off, give your regulatory adviser six items — ingredient (with a natural or synthetic source declaration), use level and basis, solvent system (including restricted solvents such as ethanol), dosage form and packaging, target country and proposed claim copy — for one upfront review. Also require legal sign-off line by line on any copy containing antioxidant or anti-ageing language: this ingredient's oral literature is so abundant that copy slides into pharmacological territory very easily.

Ingredient pairings

• Resveratrol + vitamin E + ferulic acid: the classic triangle of an antioxidant network. Vitamin E blocks oxidation chains in the oil phase, ferulic acid is described in the literature as helping stabilise other antioxidants, and resveratrol handles direct scavenging — three different jobs, and the combination is usually more stable than any of them alone.
• Resveratrol + ergothioneine: two different protection routes stacked. For the ergothioneine pathway see our ergothioneine eye care guide (ingredient.html?s=ergothioneine); the two differ in aqueous solubility and stability window, so pre-dissolve and verify each separately.
• Resveratrol + sodium hyaluronate + panthenol: an antioxidant lead with a hydration base, offsetting any dryness and supporting tolerance around the eyes — the most common structure in eye-area lines.
• Resveratrol + niacinamide: a pairing often discussed together in the literature. But their pH and colour windows differ, so verify both colour and assay retention after combining, and keep each claim inside its own boundary.
• Resveratrol + a vitamin C derivative (such as 3-o-ethyl ascorbic acid): the reduction route complementing the phenolic route, well suited to a "daytime protective" positioning; do not combine directly with high-acidity native vitamin C, since low pH and an oxidising environment suit neither.
• Use with care: avoid alkaline systems and high pH (dissolved resveratrol loses stability as pH rises); metal ions (iron, copper) catalyse oxidative discolouration, so use a chelator and assess metal pack components; strongly oxidising ingredients in the same system accelerate loss; and avoid stacking several high-dose phenolic antioxidants, since colour drift, cost and irritation all become unmanageable — cap the formula at two to three headline actives.

Formulation pairing cards

FAQ

Image briefs